| Business Summary | | Ciphergen
Biosystems,
Inc.
develops,
manufactures
and
markets
its
ProteinChip
System
using
patented
Surface
Enhanced
Laser
Desorption/Ionization
technology.
The
ProteinChip
System
enables
protein
discovery,
characterization
and
assay
development
to
provide
researchers
with
a
better
understanding
of
biological
functions
at
the
protein
level.
Protein
characterization
is
the
determination
of
the
detailed
identity
of
a
protein,
including
its
sequence
as
predicted
by
the
corresponding
gene
and
any
chemical
modifications
introduced
after
the
protein
is
produced.
Assay
development
is
the
simplification
and
optimization
of
a
set
of
procedures
to
develop
a
method
for
quantifying
a
specific
protein.
The
Company
has
commercially
launched
its
ProteinChip
System,
Series
PBS
II,
which
consists
of
disposable
ProteinChip
Arrays,
a
ProteinChip
Reader
and
its
proprietary
ProteinChip
Software. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Ciphergen
Biosystems
develops,
manufactures
and
markets
the
ProteinChip
System,
enabling
protein
discovery,
characterization
and
assay
development
to
provide
researchers
with
a
better
understanding
of
biological
functions
at
the
protein
level.
For
the
six
months
ended
6/30/01,
revenue
rose
74%
to
$6.3
million.
Net
loss
applicable
to
Common
decreased
68%
to
$11.8
million.
Results
reflect
increased
unit
sales
of
ProteinChip
systems,
partially
offset
by
higher
R&D
costs. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| John Young, 68 Chairman | -- | William Rich, Ph.D., 56 Pres,
CEO, Director | $442K | David DeNola, 51 VP-Operations | 202K | Martin Verhoef, 41 VP
of Sales and Marketing | 182K | Christopher Pohl, 49 VP-R&D | 183K | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|